SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-24-010158
Filing Date
2024-03-15
Accepted
2024-03-15 17:28:25
Documents
97
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 3786874
2 ex4-vi.htm EX-4 87215
3 ex31-1.htm EX-31.1 18170
4 ex31-2.htm EX-31.2 18556
5 ex32-1.htm EX-32.1 8277
6 ex32-2.htm EX-32.2 8228
7 ex97-1.htm EX-97.1 55058
8 form10-k_002.jpg GRAPHIC 53330
  Complete submission text file 0001493152-24-010158.txt   15178961

Data Files

Seq Description Document Type Size
9 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cldi-20231231.xsd EX-101.SCH 112166
10 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cldi-20231231_cal.xml EX-101.CAL 99394
11 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cldi-20231231_def.xml EX-101.DEF 563296
12 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cldi-20231231_lab.xml EX-101.LAB 815807
13 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cldi-20231231_pre.xml EX-101.PRE 637045
99 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 2243301
Mailing Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121 858-794-9600
Calidi Biotherapeutics, Inc. (Filer) CIK: 0001855485 (see all company filings)

IRS No.: 862967193 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40789 | Film No.: 24756123
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)